Picture of BioForce Nanosciences Holdings logo

BFNH BioForce Nanosciences Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
Consumer CyclicalsHighly SpeculativeMicro CapNeutral

Annual cashflow statement for BioForce Nanosciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.031-0.068-0.047-158-0.502
Non-Cash Items0.0010.0161580
Other Non-Cash Items
Changes in Working Capital0.0050.0040.0060.3280.424
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-0.026-0.062-0.024-0.08-0.078
Other Investing Cash Flow Items0000
Other Investing Cash Flow
Cash from Investing Activities0000
Financing Cash Flow Items0.0670.049
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities0.0260.0780.0480.0670.049
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash00.0150.024-0.013-0.029

Or unlock with your email

Or unlock with your email